Clinical Trial Update: Treatment of MB07133 Plus Sintilimab in Patients With Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A multi-phase clinical trial evaluating MB07133 plus sintilimab in hepatocellular carcinoma to assess safety and efficacy; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• MB07133
• Sintilimab (sintilimab)

Snippet

Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd. | Conditions: Safety Issues, Efficacy | Phase 1, Phase 2 | Status: UNKNOWN